These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17506292)

  • 21. [Mixed anginas: therapeutic implications].
    Pereira WI; Maseri A
    Arq Bras Cardiol; 1992 Feb; 58(2):87-9. PubMed ID: 1364031
    [No Abstract]   [Full Text] [Related]  

  • 22. Ranolazine: a new option in the management of chronic stable angina.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of anti-angina agents: studies in Italy (1963-1974)].
    Scardi S; Alberti E; Borgioni L; Medugno G; Camerini F
    Boll Soc Ital Cardiol; 1976; 21(9):1557-9. PubMed ID: 21675
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug therapy of angina pectoris. Theoretical bases and clinical management].
    Nager F
    Schweiz Med Wochenschr; 1972 Nov; 102(47):1724-9. PubMed ID: 4405291
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target?
    Herman M; Donovan J; Tran M; McKenna B; Gore JM; Goldberg RJ; Tighe DA
    Am Heart J; 2009 Sep; 158(3):378-85. PubMed ID: 19699860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-receptor blockaders and angina pectoris].
    de Sépibus G
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):979-82. PubMed ID: 4147248
    [No Abstract]   [Full Text] [Related]  

  • 28. Ranolazine: new approach for the treatment of stable angina pectoris.
    Stanley WC
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):821-9. PubMed ID: 16181027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.
    Gislason GH; Rasmussen JN; Abildstrom SZ; Schramm TK; Hansen ML; Buch P; Sørensen R; Folke F; Gadsbøll N; Rasmussen S; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2007 Aug; 116(7):737-44. PubMed ID: 17646585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 5. 2. Adrenergic beta receptor blockaders].
    Lumholtz IB
    Sygeplejersken; 1980 Mar; 80(10):11. PubMed ID: 6102418
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of diuretic therapy on exercise capacity in patients with chronic angina and preserved left ventricular function.
    Finimundi HC; Caramori PA; Parker JD
    J Cardiovasc Pharmacol; 2007 May; 49(5):275-9. PubMed ID: 17513945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angioplasty in stable angina pectoris. Not cost effective compared to drug treatment].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2009 Feb; 153(7):272-3. PubMed ID: 19291940
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. Part 6. 2. Adrenergic beta-blockers].
    Lumholtz IB
    Sygeplejersken; 1980 Mar; 80(12):23. PubMed ID: 6104366
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. Part 7. 2. Adrenergic beta-blockers].
    Lumholtz IB
    Sygeplejersken; 1980 Apr; 80(14):27. PubMed ID: 6104367
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.
    Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
    Cardiology; 2008; 111(2):126-33. PubMed ID: 18376124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New data in the diagnosis and treatment of stable angina pectoris].
    Kárpáti P
    Orv Hetil; 2006 May; 147(20):917-23. PubMed ID: 16776046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directions.
    Chaitman BR
    Can J Cardiol; 2005 Oct; 21(12):1031-4. PubMed ID: 16234885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The editor's roundtable: chronic stable angina pectoris.
    Friedewald VE; King SB; Pepine CJ; Vetrovec GW; Roberts WC
    Am J Cardiol; 2007 Dec; 100(11):1635-43. PubMed ID: 18036361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.